Akebia Therapeutics, Inc.

NasdaqCM:AKBA Stock Report

Market Cap: US$284.7m

Akebia Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:AKBA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
29 Feb 24SellUS$11,327Steven BurkeIndividual7,169US$1.58
29 Feb 24SellUS$9,439Nicole HadasIndividual5,974US$1.58
29 Feb 24SellUS$13,684Michel DahanIndividual8,661US$1.58
29 Feb 24SellUS$73,581John ButlerIndividual46,570US$1.58
27 Feb 24SellUS$57,354John ButlerIndividual37,733US$1.52
27 Feb 24SellUS$16,331Michel DahanIndividual10,744US$1.52
01 Feb 24SellUS$40,842Steven BurkeIndividual24,311US$1.68
01 Feb 24SellUS$78,102John ButlerIndividual46,489US$1.68
25 May 23SellUS$116,760Michel DahanIndividual95,478US$1.22
25 May 23SellUS$77,270Nicole HadasIndividual63,186US$1.22
16 May 23SellUS$67,890David SpellmanIndividual63,567US$1.07
16 May 23SellUS$67,890Steven BurkeIndividual63,567US$1.07

Insider Trading Volume

Insider Buying: AKBA insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of AKBA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,7040.000814%
Individual Insiders6,046,8482.89%
VC/PE Firms14,202,5586.78%
Institutions38,633,06518.5%
General Public150,488,10071.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.6%.


Top Shareholders

Top 25 shareholders own 26.48% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.78%
Alerce Investment Management L.P.
14,202,558US$19.3m-12.4%31.39%
3.63%
The Vanguard Group, Inc.
7,607,472US$10.3m1.15%no data
3.3%
Acadian Asset Management LLC
6,915,503US$9.4m-4.26%0.03%
2.28%
Renaissance Technologies LLC
4,779,383US$6.5m51.5%0.01%
1.49%
BlackRock, Inc.
3,122,824US$4.2m27.3%no data
1.24%
Millennium Management LLC
2,599,987US$3.5m-14.8%no data
1.03%
Susquehanna International Group, LLP, Asset Management Arm
2,159,364US$2.9m188%no data
0.96%
Muneer Satter
2,002,561US$2.7m0%no data
0.89%
Jacobs Levy Equity Management Inc
1,856,925US$2.5m8.02%0.01%
0.86%
Geode Capital Management, LLC
1,801,690US$2.5m4.49%no data
0.7%
John Butler
1,467,811US$2.0m11.1%no data
0.41%
Federated Hermes, Inc.
866,554US$1.2m-10.2%no data
0.34%
Michel Dahan
706,932US$961.4k121%no data
0.33%
Steven Burke
695,840US$946.4k157%no data
0.32%
Morgan Stanley, Investment Banking and Brokerage Investments
673,779US$916.3k63.6%no data
0.32%
Nicole Hadas
663,259US$902.0k79.1%no data
0.3%
Connor, Clark & Lunn Investment Management Ltd.
620,319US$843.6k-0.61%no data
0.29%
State Street Global Advisors, Inc.
610,550US$830.3k-6.99%no data
0.28%
FMR LLC
579,490US$788.1k-9.18%no data
0.15%
Northern Trust Global Investments
310,368US$422.1k2.73%no data
0.15%
Citigroup Inc.,Banking and Securities Investments
305,606US$415.6k100%no data
0.12%
Qube Research & Technologies Ltd
257,173US$349.8k112%no data
0.12%
ExodusPoint Capital Management, LP
242,974US$330.4k0%no data
0.096%
Sapient Capital, LLC
200,000US$272.0k0%0.01%
0.09%
Citadel Advisors LLC
188,594US$256.5k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.